Formulation development of Carvedilol compression coated tablet

Pharmaceutical Development and Technology

Volumn 18, Issue 4, 2013, Pages 906-915

  Shah, Ritesh ^a   Patel, Sachin ^a   Patel, Hetal ^a   Pandey, Sonia ^a   Shah, Shailesh ^a   Shah, Dinesh ^a  

^a UKA TARSADIA UNIVERSITY   (India)

Author keywords

Biphasic release; HPMC K4M; PEOWSR 205

Indexed keywords

CARVEDILOL;

ANGLE OF REPOSE; ARTICLE; BULK DENSITY; COMPRESSIBILITY INDEX; COMPRESSION COATED TABLET; DRUG FORMULATION; HARDNESS; IN VITRO STUDY; PARTICLE SIZE; PHYSICAL PARAMETERS; POWDER; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TABLET DISINTEGRATION; TABLET FORMULATION; THICKNESS; WEIGHT;

ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG COMPOUNDING; EXCIPIENTS; HARDNESS; METHYLCELLULOSE; POLYETHYLENE GLYCOLS; PROPANOLAMINES; TABLETS; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 84877862065     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2011.598167     Document Type: Article

References (25)

1. Conte U, Giunchedi P, Maggi L, et al. Ibuprofen delayed release dosage form: a proposal for the preparation of an in vitro/in vivo pulsatile system. Eur. J. Pharm. Biopharm 1992;38:209-212.
2. Gunsel W, Dusel R. Compression Coated and layer tablets. In Liberman, HA, Lachman L, Schwartz JB, eds. Pharmaceutical Dosage forms: Tablets. 2nd ed., Marcel Dekker, INC, New York, 1989: 247-284.
3. Shiyani B, Gattani S, Surana S. Formulation and evaluation of bi-layer tablet of metoclopramide hydrochloride and ibuprofen. AAPS PharmSciTech 2008;9:818-827.
4. Sockan GN, Mani KT. Challenges in the formulation of bilayered tablets A Review. Int. j. pharm. res. and dev. 2010;2:5.
5. Lopes CM, Lobo JM, Pinto JF, Costa PC. Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofen. AAPS PharmSciTech 2007;8:E76.
6. Drug bank. Available at: http://www.drugbank.ca/search/search?query= carvedilol [Website]. Accessed on Feb 12, 2009.
7. Maggi L, Machiste EO, Torre ML, Conte U. Formulation of biphasic release tablets containing slightly soluble drugs. Eur J Pharm Biopharm 1999;48:37-42.
8. Colombo P, Bettini R, Santi P, Peppas NA. Swellable matrices for controlled drug delivery: gel-layer behavior, mechanisms and optimal performance. Pharm Sci Technol Today 1999;2:225-227.
9. Kiil S, Dam-Johansen K. Controlled drug delivery from swellable hydroxypropylmethylcellulose matrices: model-based analysis of observed radial front movements. J Control Release 2003;90:1-21.
10. Kim CJ. Drug release from compressed hydrophilic POLYOX-WSR tablets. J Pharm Sci 1995;84:303-306.
11. Patel GM, Patel MM. Compressed matrix dual-component vaginal drug delivery system containing metoclopramide hydrochloride. Acta Pharm 2009;59:273-288.
12. Costa P. An alternative method to the evaluation of similarity factor in dissolution testing. Int J Pharm 2001;220:77-83.
13. CDER. Center for Drug Evaluation and Research, Guidance for Industry, Dissolution Testing of Immediate Release Solid Oral Dosage; 1997. Available from: http://www.fda.gov/cder/Guidance/1713bp1.pdf [Website]. Accessed on July 1, 2009
14. Dave BS, Amin AF, Patel MM. Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation. AAPS PharmSciTech 2004;5:e34.
15. Prior A, Frutos P, Correa CP. Comparison of dissolution profiles: Current guidelines. Docencia. Available from: http://www.sefig. com/doc/ Congreso%20Granada/013-DOC.pdf [Website]. Assed on February 23, 2009.
16. Gibaldi M, Feldman S. Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. J Pharm Sci 1967;56:1238-1242.
17. Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci 1969;58:1253-1257.
18. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci 1961;50:874-875.
19. Higuchi T. Mechanism of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145-1149.
20. Cobby J, Mayersohn M, Walker GC. Influence of shape factors on kinetics of drug release from matrix tablets. II. Experimental. J Pharm Sci 1974;63:732-737.
21. Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem 1931;23:923-931.
22. Korsmeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25-35.
23. Verma S, Narang S. Development and in vitro evaluation of floating matrix tablets of anti Retroviral drug. Int J Pharm Pharm Sci 2011;3:208-211.
24. Körner A, Piculell L, Iselau F, Wittgren B, Larsson A. Influence of different polymer types on the overall release mechanism in hydrophilic matrix tablets. Molecules 2009;14:2699-2716.
25. Yamsani VV, Gannu R, Kolli C, Rao ME, Yamsani MR. Development and in vitro evaluation of buccoadhesive carvedilol tablets. Acta Pharm 2007;57:185-197.